Functional analysis of the congenital heart disease‑associated GATA4 H436Y mutation in vitro

Area of Science:

• Genetics
• Developmental Biology
• Cardiovascular Research

Background:

• Congenital heart disease (CHD) is a leading cause of infant morbidity.
• The GATA4 transcription factor is crucial for embryonic and cardiac development.
• A specific GATA4 mutation (c.1306C>T, p.H436Y) was previously identified in infants with CHD.

Purpose of the Study:

• To functionally analyze the in vitro effects of the GATA4 H436Y mutation.
• To compare the functional impact of the mutated GATA4 protein with the wild-type.
• To investigate the mutation's role in the pathogenesis of congenital heart defects.

Main Methods:

• In vitro functional assays including dual-luciferase reporter assays and immunofluorescence.
• Electrophoretic mobility-shift assays (EMSA) to assess GATA4 binding affinity to HAND2.
• Comparison of mutated GATA4 (H436Y) with wild-type GATA4.

Main Results:

• The GATA4 H436Y mutation did not affect nuclear localization in transfected cells.
• The mutation significantly reduced the binding affinity of GATA4 to the HAND2 gene.
• Transcriptional activation of HAND2 by GATA4 was significantly decreased by the H436Y mutation.

Conclusions:

• The GATA4 H436Y mutation may not alter cellular localization but impairs GATA4's interaction with HAND2.
• Reduced binding affinity and transcriptional activity suggest a role for this GATA4 mutation in CHD pathogenesis.
• Further investigation into this specific GATA4 mutation is warranted for understanding CHD development.